1927 related articles for article (PubMed ID: 6158632)
1. Antigenic differences among B16 melanoma variants selected for their differing abilities to metastasize: a possible mechanism for effective adjuvant immunotherapy.
Steele G; Wang BS; Ghavamzadah G; Fallon M; Richie J; Wilson RE; Mannick JA
J Surg Oncol; 1980; 15(1):71-83. PubMed ID: 6158632
[No Abstract] [Full Text] [Related]
2. In vivo effects and parallel in vitro cytotoxicity of splenocytes harvested from treated or control C57BL/6J mice after adjuvant immunotherapy of pulmonary metastases using xenogeneic RNA specific to B16 murine melanoma.
Wang BS; Steele G; Mannick JA; Fallon M; Onikul SR
Cancer Res; 1979 May; 39(5):1702-7. PubMed ID: 427807
[No Abstract] [Full Text] [Related]
3. Increased immunogenicity of B16 melanoma clones selected for their ability to metastasize from a heterogeneous primary tumor.
Steele GD; Richie JP; Wang BS; Mannick JA; Wilson RE
Surg Forum; 1979; 30():132-3. PubMed ID: 538574
[No Abstract] [Full Text] [Related]
4. Prevention of death from metastases by immune RNA therapy.
Wang BS; Onikul SR; Mannick JA
Science; 1978 Oct; 202(4363):59-60. PubMed ID: 694519
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and cross-protection among B16 melanoma variants with differing proclivities to metastasize.
Harte PJ; Steele G; Munroe AE; Rayner AA; Wang BS; Wilson RE; Mannick JA
J Surg Oncol; 1981; 18(4):381-8. PubMed ID: 7321567
[TBL] [Abstract][Full Text] [Related]
6. [The inhibitory effect of batroxobin against the lung metastasis of the B16-F10 melanoma cells implanted in the mice in relation to the activity of the NK cell].
Kawachi S
Nihon Ika Daigaku Zasshi; 1988 Apr; 55(2):201-8. PubMed ID: 3164725
[No Abstract] [Full Text] [Related]
7. The control of tumor metastasis.
Gorelik E; Fogel M; Segal S; Feldman M
Results Probl Cell Differ; 1980; 11():233-40. PubMed ID: 7444196
[No Abstract] [Full Text] [Related]
8. [Antitumor effect of human interferon-alpha A/D in mice (II). Activation of natural killer cells and suppression of metastasis].
Yokoyama T; Yoshie O; Aso H; Ebina T; Ishida N
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):510-5. PubMed ID: 2988456
[TBL] [Abstract][Full Text] [Related]
9. Immune RNA in tumor immunology.
Kern DH; Pilch YH
Ann N Y Acad Sci; 1979; 332():196-206. PubMed ID: 93862
[No Abstract] [Full Text] [Related]
10. Activation of K cells in mice with transplanted tumours differing in immunogenicity and metastasizing capacity.
Mantovani A; Polentarutti N; Alessandri G; Vecchi A; Giuliani F; Spreafico F
Br J Cancer; 1977 Oct; 36(4):453-60. PubMed ID: 588412
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations.
Tamura Y; Peng P; Liu K; Daou M; Srivastava PK
Science; 1997 Oct; 278(5335):117-20. PubMed ID: 9311915
[TBL] [Abstract][Full Text] [Related]
12. Role of natural killer cells in intraocular melanoma metastasis.
Yokoyama T; Yoshie O; Aso H; Ebina T; Ishida N; Mizuno K
Invest Ophthalmol Vis Sci; 1986 Apr; 27(4):516-8. PubMed ID: 3957568
[TBL] [Abstract][Full Text] [Related]
13. Lung colonization and metastasis by disseminated B16 melanoma cells: H-2 associated control at the level of the host and the tumor cell.
Taniguchi K; Kärre K; Klein G
Int J Cancer; 1985 Oct; 36(4):503-10. PubMed ID: 4044058
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy with RNA in cancer.
Wang BS; Steele G; Onikul SR; Mannick JA
Ann N Y Acad Sci; 1979; 332():207-15. PubMed ID: 294831
[TBL] [Abstract][Full Text] [Related]
15. Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2.
Mazumder A; Rosenberg SA
J Exp Med; 1984 Feb; 159(2):495-507. PubMed ID: 6141211
[TBL] [Abstract][Full Text] [Related]
16. Reduction of pulmonary metastases of B16 melanoma by human recombinant interleukin 2 and lymphokine-activated killer cells in immunosuppressed C57BL/6 mice receiving anticancer agent.
Saijo N; Ozaki A; Sakurai M; Ishihara J; Takahashi H; Sasaki Y; Hoshi A; Hamburger AW
Jpn J Cancer Res; 1986 May; 77(5):487-93. PubMed ID: 3089980
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated antigenic differences between the primary and the descendant metastatic tumor cell populations.
Gorelik E; Fogel M; Segal S; Feldman M
J Supramol Struct; 1979; 12(3):385-402. PubMed ID: 94933
[TBL] [Abstract][Full Text] [Related]
18. Antimetastatic effect of Lactobacillus casei YIT9018 (LC 9018) on a highly metastatic variant of B16 melanoma in C57BL/6J mice.
Matsuzaki T; Yokokura T; Azuma I
Cancer Immunol Immunother; 1987; 24(2):99-105. PubMed ID: 3103914
[TBL] [Abstract][Full Text] [Related]
19. Autolymphocyte therapy--I. In vivo tumour-specific adoptive cellular therapy of murine melanoma and carcinoma using ex vivo activated memory T-lymphocytes.
Gold JE; Osband ME
Eur J Cancer; 1994; 30A(12):1871-82. PubMed ID: 7880620
[TBL] [Abstract][Full Text] [Related]
20. Role of natural killer cells in tumor growth and metastasis: C57BL/6 normal and beige mice.
Talmadge JE; Meyers KM; Prieur DJ; Starkey JR
J Natl Cancer Inst; 1980 Nov; 65(5):929-35. PubMed ID: 6933263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
